Vinay Umarji And Sohini Das

Stories by Vinay Umarji And Sohini Das

Auto Industry Sweats As Semiconductor Shortage Persists

Auto Industry Sweats As Semiconductor Shortage Persists

Rediff.com   10 Mar 2023

Open order books in February breach 700,000; wait period for some models exceed a year.

Maruti Sold 584,126 Cars In Rural Markets

Maruti Sold 584,126 Cars In Rural Markets

Rediff.com   6 Mar 2023

Maruti Suzuki says it has sold at least one car in 418,000 villages.

Why electric two-wheelers missed the ambitious 1 million sales target

Why electric two-wheelers missed the ambitious 1 million sales target

Rediff.com   1 Mar 2023

With just a month left in this financial year, electric two-wheeler sales, so far, are at just 62 per cent of the ambitious target of 1 million units set for 2022-23 by the NITI Aayog. According to VAHAN data, compiled by the Society of Manufacturers of Electric Vehicles (SMEV), 620,006 units of electric two-wheelers were sold across the country in FY23 until February 21. Though the industry may miss the 1-million target, sales in FY23 are already up 146 per cent from 249,621 units sold in FY22.

Students From Ukraine Look Elsewhere

Students From Ukraine Look Elsewhere

Rediff.com   28 Feb 2023

Of the 18,000 medical students who returned to India last year, 5,000-7,000 have either shifted to universities in Georgia, Russia, Serbia, Uzbekistan, Kyrgyzstan, Kazakhstan and Moldova or are in the process of seeking a transfer to those.

With 33% market share, Maruti eyes top slot in SUV space by FY24

With 33% market share, Maruti eyes top slot in SUV space by FY24

Rediff.com   16 Feb 2023

Maruti Suzuki India (MSIL) - the market leader in small cars - is eyeing the top spot in the sports utility vehicle (SUV) segment within a year - with a 33 per cent share of the pie. The company has been selling two SUVs - the Brezza and the Grand Vitara - and will start deliveries of the Jimny and the Fronx from March-end, and has set a target of growing its share from the current 11.5 per cent of the SUV market to 33 per cent by the end of 2023-24. The SUV segment is roughly about 42 per cent of the total passenger vehicle market, or around 1.3 million units.

'A creative mind never ages'

'A creative mind never ages'

Rediff.com   26 Jan 2023

Balkrishna V Doshi, who won the Pritzker Award in 2018 -- which is equivalent to the Nobel Prize in architecture -- passed into the ages this week. Sohini Das recalls an encounter with the the legendary architect, who was posthumously awarded the Padma Vibhushan in this year's Republic Day honours list.

More Women Buy Luxury Cars In Post-pandemic Shift

More Women Buy Luxury Cars In Post-pandemic Shift

Rediff.com   26 Jan 2023

Dealerships, too, are going all out to roll out the red carpet for women.

GM, Ford switch off India ops but unable to exit

GM, Ford switch off India ops but unable to exit

Rediff.com   25 Jan 2023

Both are finding it difficult to sell one each of their plants -- Chennai Maraimalai Nagar (Ford) and Talegaon near Pune (GM) -- and are finding the road blocked by employee severance snarl-ups, report Sohini Das and Shine Jacob.

'None of the existing vaccines can prevent emerging variants of Omicron'

'None of the existing vaccines can prevent emerging variants of Omicron'

Rediff.com   25 Jan 2023

'We seem to be in a situation where we can do little, and nothing needs to be done anyway.'

Bajaj's e-Chetak to speed into Europe by 2024

Bajaj's e-Chetak to speed into Europe by 2024

Rediff.com   21 Jan 2023

The electric Chetak has already sold close to 25,000 units in India, and the European version will be based on the same platform.

Why luxury carmakers will see quicker transition to EVs

Why luxury carmakers will see quicker transition to EVs

Rediff.com   19 Jan 2023

While Mercedes-Benz India expects 25 per cent of its India sales to come from EVs in the next four years, BMW says it estimates around 10 per cent of sales to come from those in the near future.

Field testing started for fuel-agnostic engines

Field testing started for fuel-agnostic engines

Rediff.com   19 Jan 2023

Cummins India will soon start producing fuel-agnostic engine systems at the Tata-Cummins plant in Phaltan in Satara district of Maharashtra, senior officials at Cummins India said. The firm will start limited production by the end of 2023 and mass production will likely begin by 2024, the officials said.

India 'Stay Calm' About Kraken: Experts

India 'Stay Calm' About Kraken: Experts

Rediff.com   16 Jan 2023

The Kraken COVID-19 variant accounts for almost 41 per cent of all Covid infections.

What Employees Can Expect In 2023

What Employees Can Expect In 2023

Rediff.com   5 Jan 2023

'Enterprises have become more demanding in terms of their productivity expectation from their employees.'

Top Carmakers Post Double-Digit Export Growth With Maruti At The Wheel

Top Carmakers Post Double-Digit Export Growth With Maruti At The Wheel

Rediff.com   4 Jan 2023

Clock 11% growth in the first 11 months of 2022.

Doctors want govt to allow 4th booster

Doctors want govt to allow 4th booster

Rediff.com   4 Jan 2023

'The protective effect of the vaccine lasts for about nine months to a year.' 'For health workers that period is already over. This is the right time to augment their immunity.'

Why Is USFDA Inspecting India Pharma Firms?

Why Is USFDA Inspecting India Pharma Firms?

Rediff.com   30 Dec 2022

Indian drug firms continue to work closely with the FDA, and most have also appointed consultants to help them grasp the regulatory minutiae in the US.

Indians Not Taking Booster Covid Vaccine

Indians Not Taking Booster Covid Vaccine

Rediff.com   30 Dec 2022

Less than 30,000 booster doses daily in December.

Checks On Drug-Making Units Begins

Checks On Drug-Making Units Begins

Rediff.com   29 Dec 2022

The joint inspections is to ensure the safety, efficacy, and quality of drugs available in the country

Nasal Covid Vaccine Available In Jan

Nasal Covid Vaccine Available In Jan

Rediff.com   28 Dec 2022

The vaccine would not have production scalability issues unlike Covaxin, Bharat Biotech's COVID-19 virus vaccine.